Article Figures & Data
Figures
- Figure 1.
Patient screening, enrollment, and follow-up flowchart. CAD, coronary artery disease; GES, gene expression score.
- Figure 2.
Treatment decision before and after gene expression testing. GES, gene expression score.
Tables
Characteristics Patients Clinical factors Female sex 140 (56) Age (years) 56.2 ± 13 Non-Hispanic white ethnicity 224 (89) Presenting symptoms Typical angina 31 (12) Atypical angina 67 (27) Noncardiac chest pain 56 (22) Shortness of breath 50 (20) Malaise/fatigue 47 (19) Cardiac risk factors Hypertension 120 (48) Dyslipidemia 146 (58) Body mass index 29.7 ± 6.7 Systolic/diastolic blood pressure (mm Hg) 128/79 Gene expression score 16.0 ± 10.0 Data are n (%) or mean ± standard deviation unless otherwise indicated.
- Table 2. Association of Testing Changes Among Patients with Low and Elevated Gene Expression Scores
Testing Intensity Score Class All ≤15 >15 Decreased 76 (60) 17 (14) 93 No change 48 (38) 58 (47) 106 Increased 3 (2) 49 (39) 52 All 127 (100) 124 (100) 251 Data are n (%). P <.00001, exact test.
In this issue
Jump to section
Related Articles
Cited By...
- Scoping review of enablers and challenges of implementing pharmacogenomics testing in the primary care settings
- The Expressed Genome in Cardiovascular Diseases and Stroke: Refinement, Diagnosis, and Prediction: A Scientific Statement From the American Heart Association
- Genomics-Inspired Biomarkers and Diagnostics--Where Are They?
- Investigating Patient-Centered Care